These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32682887)

  • 21. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
    Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
    J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
    [No Abstract]   [Full Text] [Related]  

  • 22. Acquired dysplastic melanocytic nevi and cutaneous melanoma: precursors and prevention.
    Rhodes AR
    Ann Intern Med; 1985 Apr; 102(4):546-8. PubMed ID: 3977199
    [No Abstract]   [Full Text] [Related]  

  • 23. Gene expression profiling of melanocytic lesions.
    Seykora JT; Jih D; Elenitsas R; Horng WH; Elder DE
    Am J Dermatopathol; 2003 Feb; 25(1):6-11. PubMed ID: 12544092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BAP1 deficient malignant melanoma arising from the intradermal component of a congenital melanocytic naevus.
    Ardakani NM; Palmer DL; Wood BA
    Pathology; 2015 Dec; 47(7):707-10. PubMed ID: 26517632
    [No Abstract]   [Full Text] [Related]  

  • 25. ESP, EORTC, and EURACAN Expert Opinion: practical recommendations for the pathological diagnosis and clinical management of intermediate melanocytic tumors and rare related melanoma variants.
    de la Fouchardiere A; Blokx W; van Kempen LC; Luzar B; Piperno-Neumann S; Puig S; Alos L; Calonje E; Massi D; ; ;
    Virchows Arch; 2021 Jul; 479(1):3-11. PubMed ID: 33432480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.
    Sand M; Skrygan M; Georgas D; Sand D; Gambichler T; Altmeyer P; Bechara FG
    Cell Tissue Res; 2012 Oct; 350(1):119-26. PubMed ID: 22706980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma.
    Clarke LE; Pimentel JD; Zalaznick H; Wang L; Busam KJ
    Hum Pathol; 2017 Dec; 70():113-120. PubMed ID: 29079183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Increased risk of developing a second primary cutaneous nevus-associated melanoma in patients previously diagnosed with the disease].
    Echeverría B; Botella-Estrada R; Serra-Guillén C; Martorell A; Traves V; Requena C; Sanmartín O; Llombart B; Guillén C; Nagore E
    Actas Dermosifiliogr; 2010 Oct; 101(8):710-6. PubMed ID: 20965014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
    de Jel MM; Engelmann JC; Kunz M; Schiffner S; Kuphal S; Bosserhoff AK
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):678-80. PubMed ID: 24661573
    [No Abstract]   [Full Text] [Related]  

  • 30. Congenital melanocytic nevi and DNA content. An analysis by flow and image cytometry.
    Barnhill RL; Aguiar M; Cohen C; Kang S; Kennedy J; Schmidt B; Sober AJ; Solomon AR
    Cancer; 1994 Dec; 74(11):2935-43. PubMed ID: 7954257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant melanoma arising from an NRAS-mutated medium-sized congenital melanocytic nevus.
    Kiyohara T; Takata M; Itoh H; Kawami K; Ido H; Ishida H; Kumakiri M
    J Dermatol; 2012 Dec; 39(12):1034-5. PubMed ID: 22452623
    [No Abstract]   [Full Text] [Related]  

  • 32. A murine model for the development of melanocytic nevi and their progression to melanoma.
    Nasti TH; Cochran JB; Tsuruta Y; Yusuf N; McKay KM; Athar M; Timares L; Elmets CA
    Mol Carcinog; 2016 May; 55(5):646-58. PubMed ID: 25788145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Clinical, Dermoscopic, and Histopathologic Findings With Gene Expression in Patients With Balloon Cell Melanoma.
    Friedman BJ; Stoner R; Sahu J; Lee JB
    JAMA Dermatol; 2018 Jan; 154(1):77-81. PubMed ID: 29238799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased heme oxygenase-1 expression distinguishes human melanomas from melanocytic nevi.
    Jin SA; Park JJ; Lee JB; Lee SC; Yun SJ
    Pigment Cell Melanoma Res; 2010 Dec; 23(6):841-4. PubMed ID: 20819187
    [No Abstract]   [Full Text] [Related]  

  • 35. Melanoma precursor lesions and borderline melanomas.
    Briggs JC
    Histopathology; 1985 Dec; 9(12):1251-62. PubMed ID: 3913633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant melanoma arising from giant congenital melanocytic nevus with SMARCA2 gene mutation.
    Xie Y; Zhou Z; Deng D; Liu Y
    Asian J Surg; 2024 Jul; 47(7):3320-3321. PubMed ID: 38604858
    [No Abstract]   [Full Text] [Related]  

  • 37. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
    Bauer J; Bastian BC
    Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cutaneous melanocytic tumors. Case 7].
    de la Fouchardière A
    Ann Pathol; 2016 Oct; 36(5):341-344. PubMed ID: 27639772
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Massively parallel sequencing analysis of benign melanocytic naevi.
    Lozada JR; Geyer FC; Selenica P; Brown D; Alemar B; Merghoub T; Berger MF; Busam KJ; Halpern AC; Weigelt B; Reis-Filho JS; Hollmann TJ
    Histopathology; 2019 Jul; 75(1):29-38. PubMed ID: 30791119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.